|
| Areas | Steps/questions | Answers/action taken | Remarks |
|
|
Policy | Disease burden and cost-effectiveness estimations | Annual report Ministry of Health and Family Welfare, Government of India | Done |
| Financial sustainability planning for future years | Targeting introduction into national immunization schedule | Yes |
| Advocacy and social mobilization | Participation and training of district level immunization officer (interview with DIO) | Done |
| Training and material development | Hoardings, pamphlets, banners used | Done |
| Cold chain capacity assessment | ILRs and vaccine carries used | Done |
|
|
Planning and operations | Is the implementation in progress according to the initial plan (countrywide/phased introduction, key dates)? | Phased introduction in Haryana, and dates (15/7/08 to 31/7/08) were ensured after vaccine stocks (as interview with DIO) | Done |
| Is there a transition plan, if the country has or is planning to switch from one vaccine presentation to another? | Shifted from mouse brain vaccine to live attenuated vaccine | No |
| Are specific adverse events following immunization (AEFIs) for new vaccine recognized and reported in timely fashion? | Cases of AEFI following vaccine administration were discussed and managed | Done |
| Is surveillance for the new vaccine-related disease or condition in place? | Integrated Diseases Surveillance Program is in operation | Done |
|
|
Vaccine management | Have vaccine stockouts been experienced since introduction? | Vaccine supply was ensured before implementation (declaration of dates) | Done |
| Is there a plan to assess the impact of new vaccine implementation? | Reduction in JE cases in the region is being documented | Done |
| What is the overall perception of introduction as judged by decision-makers and NIP team? | DIO, MOs, and health workers reported it to be useful for disease prevention | Done |
|
| Health worker practice | Are correct practices observed during handling, reconstitution, and administering of vaccines? | Observed by the supervisors (medical officers) | Done |
|
| Immunization safety | Are autodisable syringes and safety boxes used and appropriately disposed of? | Used | Done |
|
| Vaccine wastage | Is vaccine wastage recorded and monitored at the health facility level? | Recorded by health workers and monitored by medical officers | Done |
|
| Health worker knowledge | Do the health workers need additional training and supportive supervision on new vaccine? | DIO, MOs, and health workers were trained | Done |
|
| Community acceptance | Is the new vaccine well received by the community and the health workers? | Coverage was found to be 93.5% | Done |
| Can families name the new vaccine and the disease it prevents? | 48.7% of parents were able to tell about JE | Satisfactory |
|
